09.09.2021 - 16:46 [ Jasmine the European Cat / Twitter ] But the Oxford/AstraZeneca team, which uses more traditional viral vector technology, says that while it can make a new formulation in days, it takes much longer to produce. (09.02.2021) It expects to have a vaccine designed to address the variant discovered in South Africa ready by autumn.